PowerVision Secures $10,000,000 Series D Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    260 Harbor Blvd. Belmont, CA 94002 USA
  • Company Description
    The FluidVision accommodating intraocular lens (IOL) technology will restore the vision of youth to middle aged or elderly individuals affected by presbyopia and/or cataracts. Our mission is to provide a family of fluid based lens implants that solve clinical and lifestyle needs caused by these conditions thereby creating the most significant innovation in vision correction surgery since the introduction of the IOL.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds of the funding will be used to complete patient enrollment in the ongoing CE Mark study of the FluidVision accommodating intraocular lens, with patient enrollment expected to be completed by the end of the year and receipt of the CE mark and the subsequent launch of the U.S. pivotal study coming in 2015.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy